By David Tuller, DrPH I was supposed to be in Bristol, England, last week at the CFS/ME Research Collaborative conference. The conference went on as scheduled, but I decided the weekend before that the situation was getting too dicey to leave home. I didn’t want to get swept up in lockdowns and international travel blockades …
Trial By Error: My Virtual Appearance in Sheffield Read More »
By David Tuller, DrPH And here’s yet another study from Professor Trudie Chalder and colleagues at King’s College London, this time tackling fatigue in people with HIV, an often debilitating problem. The study, “A Biopsychosocial Approach to HIV Fatigue: A Cross-Sectional and Prospective Analysis to Identify Key Modifiable Factors”, was published online last month by …
Trial By Error: New Biopsychosocial Study of Fatigue in HIV Patients Read More »
By David Tuller, DrPH Leonard Jason, a professor of psychology at DePaul University in Chicago, is a recognized expert in research on the prevalence of and case definitions for the illness (or cluster of illnesses) variously referred to as myalgic encephalomyelitis, chronic fatigue syndrome, ME/CFS, CFS/ME and other names. I posted an interview with him …
Trial By Error: Simon McGrath on Leonard Jason’s Study of US Pediatric Prevalence Read More »
By David Tuller, DrPH I have been trying to find out why Mahana Therapeutics, a San Francisco-based start-up, has chosen to disseminate misleading information about a web-based cognitive behavior therapy program for people with irritable bowel syndrome. Because Mahana’s co-founder and CEO, Rob Paull, has not responded to my letters, I have contacted some of …
Trial By Error: Another Letter About Mahana; BerkeleyWellness on IBS Study Read More »
By David Tuller, DrPH When I was in Australia two years ago–wow, can’t believe it’s been that long!–I spent some time with Dr Mark Guthridge, an associate professor of biomedical science at Deakin University in Melbourne. Several years ago, after a bout of mononucleosis/glandular fever, he developed myalgic encephalomyelitis, which in Australia even patients and …
Trial By Error: An Australian Radio Interview with Melbourne’s Dr Mark Guthridge Read More »
By David Tuller, DrPH Last week, I wrote to Rob Paull, the co-founder and CEO of Mahana Therapeutics, regarding the company’s misleading claims about the web-based cognitive behavior therapy program for irritable bowel syndrome it recently licensed from King’s College London. I have also written to Professor Rona Moss-Morris, the co-lead investigator of ACTIB, the …
Trial By Error: My Follow-up Letter to Mahana Therapeutics’ CEO Read More »
